Radius Anesthesia blog
Over-reliance on opioids and the risk of patients subsequently developing opioid dependence remain significant problems within the American healthcare system, affecting tens of thousands of patients each year. While severe pain management is an important component of postoperative care, a comparison between the opioid prescribing practices in the U.S. prescribed opioids at a rate eighteen times higher than other countries for the same surgical procedures (Kaafarani et al., 2020). These differences far exceed any explanation based solely on clinical necessity. Instead, they represent the impacts of unique market forces, healthcare structures, and cultural expectations surrounding pain management in the U.S.
These disparities in prescribing practices span multiple medical fields and cannot be explained simply by procedural complexity or variation in treatment needs. The International Pattern of Opioid Prescribing (iPOP) study collected opioid prescription rates across different countries for identical routine operations, including appendectomies, cholecystectomies, and inguinal hernia repairs. Researchers found that opioids were prescribed for postoperative pain management in 91% of U.S. cases, compared to just 5% in non-U.S. countries (Kaafarani et al., 2020). The same study further found that American patients refilled opioid prescriptions at more than four times the rate of international peers (4.7% compared to 1%). This trend also extends beyond major surgeries into routine outpatient care. In dentistry, opioid prescription rates for U.S. patients were reported at 2,786 per 100,000 people, compared to only 83 per 100,000 in the Netherlands (Chua et al., 2026).
Several systemic and economic factors contribute to these differences. Compared with many nationalized European healthcare systems, the relatively decentralized and insurance-driven structure of American healthcare grants physicians broad discretion while simultaneously exposing them to aggressive pharmaceutical marketing. Research has shown that even small financial interactions, such as a pharmaceutical representative purchasing a modest meal for a physician, are associated with increased rates of subsequent opioid prescribing (Hadland et al., 2018).
Cultural expectations surrounding pain management further compound these systemic issues. Although baseline biological pain tolerance is generally consistent across populations, cultural attitudes toward expressing and treating pain vary significantly. Some studies suggest that cultural norms in parts of East Asia may discourage overt expressions of pain, potentially influencing attitudes toward narcotic use and postoperative recovery. Conversely, American culture often emphasizes the complete elimination of pain rather than gradual management, which may contribute to the elevated refill rates observed in the iPOP study. An ongoing challenge for clinicians is to balance effective pain management with realistic expectations regarding recovery and discomfort.
These expectations surrounding postoperative care also influence patient satisfaction metrics within the American healthcare system. In many hospital networks, patient satisfaction scores can affect physician compensation, institutional reimbursement, and professional evaluations. As a result, physicians may face pressure to prioritize immediate pain relief in order to avoid poor evaluations or negative online reviews that could affect the reputation of their practice. This dynamic can create a perverse incentive to prescribe opioids more aggressively than may be medically necessary.
Ultimately, the less restrictive opioid prescribing practices seen in the U.S. in comparison to other countries is tied to a unique combination of sociocultural expectations and economic incentives. Meaningful reductions in opioid overprescription will therefore require systemic reform targeting both the financial structures of healthcare and broader cultural expectations surrounding pain treatment.
References
- Kaafarani, H. M. A., Han, K., El Moheb, M., Kongkaewpaisan, N., Jia, Z., El Hechi, M. W., van Wijck, S., Breen, K., Eid, A., Rodriguez, G., Kongwibulwut, M., Nordestgaard, A. T., Sakran, J. V., Ezzeddine, H., Joseph, B., Hamidi, M., Ortega, C., Flores, S. L., Gutierrez-Sougarret, B. J., Qin, H., … Prichayudh, S. (2020). Opioids after surgery in the United States versus the rest of the world: The iPOP multicenter study. Annals of Surgery, 272(5), 879–886. https://doi.org/10.1097/SLA.0000000000004225
- Hadland, S. E., Rivera-Aguirre, A., Marshall, B. D. L., & Cerdá, M. (2018). Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing. JAMA Internal Medicine, 178(6), 861–863. https://doi.org/10.1001/jamainternmed.2018.1999
- Chua, K.-P., Bruno, C., Pearson, S.-A., Brett, J., He, S., Nalliah, R., & Brummett, C. (2026). International trends in dental opioid prescriptions. JAMA Network Open, 9(4),